Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy
Clinical trial NCT01852292 · TERMINATED
Trial details
- NCT number
- NCT01852292
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2017-03-30
- Enrollment
- 157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.